Summit on HIV testing and 'the neglected US epidemic'; audiobriefing 12 p.m. EST, Thurs., Nov. 20

November 20, 2008

Nearly 60,000 Americans were infected with HIV last year, and some 250,000 people nationwide are unaware of their infection. While initial successes show the potentially powerful impact of routine testing, two years after the US government's Centers for Disease Control and Prevention (CDC)'s recommendation of routine HIV testing for Americans aged 13 to 64, major barriers stand in the way of making HIV testing the nationwide norm.

More than one in five people with HIV remain unaware of their status, fail to get life-extending medical help, and many unwittingly spread the virus, contributing to more than one-half of all sexually transmitted infections.

The Forum for Collaborative HIV Research, an independent public-private partnership, will convene some 300 leading HIV researchers, health care providers and policymakers to examine the state of the U.S. epidemic, the critical role of routine testing in HIV prevention, treatment and care, and to identify barriers.

National Summit on HIV Diagnosis, Prevention and Access to Care

November 20-21, 2008

Hyatt Regency Crystal City at Reagan National Airport 2799 Jefferson Davis Highway, Arlington, VA

Press Registration:
To register as a media attendee, please email

An audiobriefing will be held on Thursday, November 20 at 12:00 PM EST. To dial in, RSVP to Katy at and the call-in information will be sent to you.

Embargoed materials:
the press release, related abstracts, a backgrounder, a live blog and audio-visual materials are available on the science news site, EurekAlert! at:

A live blog will be generated during the Summit at

Experts: If you would like to interview a researcher or HIV advocate on this topic, the following are available:

New data will examine:

With over one million infected individuals, HIV in the United States amounts to a "neglected epidemic" that needs a coordinated national response. It offers an opportunity for the new US administration to help many of the estimated 250,000 people who are unaware of the their HIV+ status to get the tests they need, begin treatment, and make behavioral changes that avoid spreading the disease. The importance of testing as part of a national AIDS strategy is reinforced by new research that shows people with the AIDS virus benefit from starting drug treatments sooner than current guidelines recommend, and can save years of healthy life.

In 2006, the US Centers for Disease Control and Prevention revised its HIV testing guidelines. It replaced written informed consent testing with voluntary "opt out" testing, and, rather than focusing solely on high risk groups, they recommended that all people 13-64 years of age receive HIV tests as a routine part of healthcare. Although studies show that there is high acceptance of such HIV screening among the public, policymakers have yet to fund and implement the programs needed to capitalize on this widespread sentiment.

The National Summit will present data that demonstrate where and how inroads have been made, illustrate the consequences of current practices, and highlight the actions needed to yield a major public health victory in the United States.

About the Forum for Collaborative HIV Research:

The Forum for Collaborative HIV Research is an independent public-private partnership whose mission is to facilitate discussion on emerging issues in HIV clinical research and the transfer of research results into care. The Forum is comprised of representatives from all stakeholders in HIV clinical research and facilitates ongoing discussion and collaboration among these stakeholders to address critical unanswered questions about the optimal medical management of HIV disease and encourage coordination among public and private research efforts.

Forum for Collaborative HIV Research

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to